|
WO2017021983A1
|
|
Particulate delivery systems
|
|
US2017128379A1
|
|
Modified release pharmaceutical preparations
|
|
WO2015037019A2
|
|
Modified release pharmaceutical formulations
|
|
WO2013183062A2
|
|
Palatable formulations of ibuprofen
|
|
WO2013175502A2
|
|
Formulations for mucosal administration
|
|
WO2013171764A2
|
|
Ophthalmic formulations
|
|
US2015079136A1
|
|
Controlled release pharmaceutical formulations of direct thrombin inhibitors
|
|
WO2013168179A2
|
|
Controlled release pharmaceutical formulations of antiviral agents
|
|
WO2013168177A2
|
|
Osmotically controlled drug delivery systems
|
|
WO2013114400A2
|
|
Compressed pharmaceutical compositions of atypical antipsychotics
|
|
WO2012127431A1
|
|
Stabilized compositions of tetrahydrobiopterin
|
|
WO2012063257A2
|
|
Sustained release compositions
|
|
WO2012035409A1
|
|
Sustained release compositions of anti-alzheimer's agents
|
|
EP2575798A1
|
|
Gastroretentive dosage forms of gaba analogs
|
|
WO2011124973A1
|
|
Excipient from trigonella foenum-graceum seeds and process for preparation thereof
|
|
WO2010143207A1
|
|
Taste-masked oral formulations of influenza antivirals
|
|
EP2346353A2
|
|
Compositions comprising fenugreek hydrocolloids
|
|
EP2355669A2
|
|
Dietary fiber compositions
|
|
WO2009084040A1
|
|
Once a day formulation of angiotensin receptor blockers
|
|
US2010215740A1
|
|
Taste-masked orally disintegrating tablets of memantine hydrochloride
|
